ABSTRACT
Background: A study related to an overview of the editorial workflow, editorial decision-making and timelines of the Indian Journal of Dermatology, Venereology and Leprology (IJDVL) had been published earlier. However, a study on publication pattern, citations, contributing organizations, most cited publications etc. of IJDVL has not been performed till now. Objectives: This study aims to identify and analyse the impact of IJDVL on various scientometric indicators viz. year-wise publication growth, impact factor trend, most contributing organizations, global outreach, most cited papers, and cited and citing journals, over the years 2007 to 2019. Methods: Data for this study were retrieved from the Web of Science-core collection database of Journal Citation Reports (Clarivate Analytics, 2021) on 12th May 2021. The search was performed by using the advanced search feature of the database. Using the “InCites”, a search for journal citation reports of IJDVL was performed. Results: The highest number of cumulative citations have been received by publications published in the year 2019 with 2,122 citations which is 91.53% in citable items. In the year 2009 journal, the impact factor was 0.976, which jumped to 2.712 (Journal Citation Reports™ 2018). IJDVL received its highest impact factor (3.030) in the year 2019. All India Institute of Medical Sciences, New Delhi is the most prolific organization contributing to IJDVL with 51 publications. Among foreign countries, China is leading with reference to most contributions by any foreign country with 51 publications in IJDVL. Journal of the American Academy of Dermatology having an impact factor 8.277 has been cited 145 times in this journal. Limitations: Only one database was used for the study. Conclusion: The high proportion of frequently cited articles in recent years, together with its currently high journal impact factor and quartile two-factor, give sustenance to the view that IJDVL publishes high-standard articles relevant to dermatology research and clinical practice
ABSTRACT
Medical representatives are important members of pharmaceutical companies. They are hired based on some specificcriteria like basic knowledge about clinical, pharmaceutical marketing, and selling skills which are suitable to interactwith healthcare providers. They provide drug’s information to healthcare professionals and help pharmaceuticalcompanies to generate the sales. After hiring for medical representative, companies provide training on many aspects.Along with scientific research knowledge, they often need to be updated and well versed with pharmaceuticalmarketing knowledge. For success of any medical representative, sound knowledge of pharmaceutical marketingis necessary. Knowledge and attitude regarding pharmaceutical marketing need to be ascertained by medicalrepresentative from time to time. Evaluation about the same was the main focus of this study. This was an exploratorystudy that involved both primary research with the help of research survey and secondary research. Target samplewas medical representatives working in various pharmaceutical companies. From the above survey, majority of themedical representatives felt that basics of pharmaceutical marketing knowledge are necessary for successful detailingand that will help them to increase sales. Adding to this, they also mentioned that they were only trained on how to readout the matter to healthcare professionals. Moreover, there are many basic pharmaceutical marketing concepts whichare needed for better understanding and successful detailing.
ABSTRACT
South Asian Association for Regional Cooperation (SAARC) and Brazil, Russia, India, China, and South Africa(BRICS) countries’ contribution in the field of science and engineering has grown immensely over the decade. BRICScountries have accelerated their efforts in healthcare, as well in the pharmaceutical sector through increased efforts inresearch and development, acquisitions, and generic drug manufacturing. Pharmacoeconomics and health outcomesresearch field give an indication about healthcare coverage and access decisions. India being significantly majorplayer among SAARC and BRICS countries in terms of economy and policy making, the present study attemptedto analyze scientific research presentation made by India compared to SAARC and BRICS countries in the area ofpharmacoeconomics and health outcomes research at International Society for Pharmacoeconomics and OutcomesResearch Meetings. The scientific research presentation abstracts published from 2008 to 2017 were included in thestudy. Research in the area of pharmacoeconomics and health outcomes studies has increased in SAARC and BRICScountries over the last 10 years. The collaborative research with foreign/international authors is also increasing, whichis an encouraging trend in this area. The research carried out by SAARC and BRICS countries in the above-said areashould be strengthened further which may be beneficial to the society in the coming years.